pSivida Corp. is engaged in developing tiny, sustained release drug-delivery products that deliver drugs at a controlled or steady rate for months or years. The company is currently focused on the treatment of chronic diseases of the back of the eye. pSivida currently has two FDA-approved products, Retisert and Vitrasert, and ILUVIEN – licensed to Alimera Sciences, Inc. – has received marketing authorization in various countries, as well as FDA Investigational New Drug (IND) clearance for treating posterior uveitis. For more information, visit the company’s Web site at www.psivida.com.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research, sales, and trading services. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.

Let us hear your thoughts below: